X

Dein Chef zahlt mit: Jetzt OSKAR VL Sparplan eröffnen und monatlich bis zu 40 Euro sichern!
WERBUNG

Lass Deinen Chef für Deinen ETF-Aufbau zahlen. Mit OSKAR VL (Vermögenswirksame Leistungen) sparst Du clever und einfach.

Jetzt VL-Bonus sichern

Nicht mehr anzeigen

Cipher Pharmaceuticals Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

7,25 EUR -0,30 EUR -3,97 %

15:17:25

STU

14,46 CAD -0,22 CAD -1,50 %

21:25:00

TSX

Cipher Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Bei einem anderen Broker handeln

Smartphone

Marktkap.234,03 Mio. EUR

KGV22,38Div. Rendite0,00%

WKNA0B85L

ISINCA17253X1050

SymbolCPHRF

Cipher Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

06.11.25PR NewswireCipher Pharmaceuticals Reports Third Quarter 2025 Results

29.10.25PR NewswireCipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

14.10.25PR NewswireCipher Pharmaceuticals Receives Successful Arbitration Award

WerbungCipher Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

26.08.25PR NewswireCipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

07.08.25PR NewswireCipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue

29.07.25PR NewswireCipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call

13.06.25PR NewswireCipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

08.05.25PR NewswireCipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment

02.05.25PR NewswireCipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call

01.05.25PR NewswireCipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block Purchases

29.04.25PR NewswireCipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba™ in the state of Illinois

18.03.25PR NewswireCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results

11.03.25PR NewswireCipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call

10.12.24PR NewswireCipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study

08.11.24PR NewswireCipher Pharmaceuticals Reports Third Quarter 2024 Results

04.11.24PR NewswireCipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call

08.10.24PR NewswireCipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer

13.09.24PR NewswireCipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study

08.08.24PR NewswireCipher Pharmaceuticals Reports Second Quarter 2024 Results

01.08.24PR NewswireCipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call

29.07.24PR NewswireCipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million

14.06.24PR NewswireCipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

09.05.24PR NewswireCipher Pharmaceuticals Reports First Quarter 2024 Results

03.05.24PR NewswireCipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call

14.03.24PR NewswireCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results

08.03.24PR NewswireCipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call

29.01.24PR NewswireCipher Pharmaceuticals Announces the Commencement of OTCQX Trading

Cipher Pharmaceuticals News

Cipher Pharmaceuticals News: auf dieser Seite finden Sie alle Cipher Pharmaceuticals News und Nachrichten zur Cipher Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Cipher Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Cipher Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.